425 related articles for article (PubMed ID: 10413294)
41. Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability.
Drori S; Eytan GD; Assaraf YG
Eur J Biochem; 1995 Mar; 228(3):1020-9. PubMed ID: 7737146
[TBL] [Abstract][Full Text] [Related]
42. ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells.
Doige CA; Yu X; Sharom FJ
Biochim Biophys Acta; 1992 Aug; 1109(2):149-60. PubMed ID: 1355666
[TBL] [Abstract][Full Text] [Related]
43. Partial reversal of multidrug resistance in human breast cancer cells by an N-myristoylated protein kinase C-alpha pseudosubstrate peptide.
Gupta KP; Ward NE; Gravitt KR; Bergman PJ; O'Brian CA
J Biol Chem; 1996 Jan; 271(4):2102-11. PubMed ID: 8567666
[TBL] [Abstract][Full Text] [Related]
44. Comparison of mechanisms responsible for resistance to idarubicin and daunorubicin in multidrug resistant LoVo cell lines.
Toffoli G; Simone F; Gigante M; Boiocchi M
Biochem Pharmacol; 1994 Nov; 48(10):1871-81. PubMed ID: 7986198
[TBL] [Abstract][Full Text] [Related]
45. Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C.
Sachs CW; Safa AR; Harrison SD; Fine RL
J Biol Chem; 1995 Nov; 270(44):26639-48. PubMed ID: 7592889
[TBL] [Abstract][Full Text] [Related]
46. Characterization of the dexniguldipine binding site in the multidrug resistance-related transport protein P-glycoprotein by photoaffinity labeling and mass spectrometry.
Borchers C; Boer R; Klemm K; Figala V; Denzinger T; Ulrich WR; Haas S; Ise W; Gekeler V; Przybylski M
Mol Pharmacol; 2002 Jun; 61(6):1366-76. PubMed ID: 12021398
[TBL] [Abstract][Full Text] [Related]
47. Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells.
Doige CA; Sharom FJ
Biochim Biophys Acta; 1992 Aug; 1109(2):161-71. PubMed ID: 1355667
[TBL] [Abstract][Full Text] [Related]
48. Melphalan resistance and photoaffinity labelling of P-glycoprotein in multidrug-resistant Chinese hamster ovary cells: reversal of resistance by cyclosporin A and hyperthermia.
Larrivée B; Averill DA
Biochem Pharmacol; 1999 Jul; 58(2):291-302. PubMed ID: 10423171
[TBL] [Abstract][Full Text] [Related]
49. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1.
Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M
Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227
[TBL] [Abstract][Full Text] [Related]
50. Drug-stimulated ATPase activity of the human P-glycoprotein.
Scarborough GA
J Bioenerg Biomembr; 1995 Feb; 27(1):37-41. PubMed ID: 7629050
[TBL] [Abstract][Full Text] [Related]
51. Stoichiometry of coupling of rhodamine 123 transport to ATP hydrolysis by P-glycoprotein.
Shapiro AB; Ling V
Eur J Biochem; 1998 May; 254(1):189-93. PubMed ID: 9652413
[TBL] [Abstract][Full Text] [Related]
52. Aureobasidin A, an antifungal cyclic depsipeptide antibiotic, is a substrate for both human MDR1 and MDR2/P-glycoproteins.
Kino K; Taguchi Y; Yamada K; Komano T; Ueda K
FEBS Lett; 1996 Dec; 399(1-2):29-32. PubMed ID: 8980113
[TBL] [Abstract][Full Text] [Related]
53. Cellular uptake and antiproliferative effects of therapeutic concentrations of idarubicin or daunorubicin and their alcohol metabolites, with or without cyclosporin A, in MDR1+ human leukemic cells.
Chiodini B; Bassan R; Barbui T
Leuk Lymphoma; 1999 May; 33(5-6):485-97. PubMed ID: 10342576
[TBL] [Abstract][Full Text] [Related]
54. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines.
van der Sandt IC; Blom-Roosemalen MC; de Boer AG; Breimer DD
Eur J Pharm Sci; 2000 Sep; 11(3):207-14. PubMed ID: 11042226
[TBL] [Abstract][Full Text] [Related]
55. Allosteric regulation of [3H]vinblastine binding to P-glycoprotein of MCF-7 ADR cells by dexniguldipine.
Ferry DR; Malkhandi PJ; Russell MA; Kerr DJ
Biochem Pharmacol; 1995 Jun; 49(12):1851-61. PubMed ID: 7598747
[TBL] [Abstract][Full Text] [Related]
56. A novel bioassay for P-glycoprotein functionality using cytochalasin D.
Elbling L; Berger W; Weiss RM; Printz D; Fritsch G; Micksche M
Cytometry; 1998 Mar; 31(3):187-98. PubMed ID: 9515718
[TBL] [Abstract][Full Text] [Related]
57. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P
Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401
[TBL] [Abstract][Full Text] [Related]
58. Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative.
Dale IL; Tuffley W; Callaghan R; Holmes JA; Martin K; Luscombe M; Mistry P; Ryder H; Stewart AJ; Charlton P; Twentyman PR; Bevan P
Br J Cancer; 1998 Oct; 78(7):885-92. PubMed ID: 9764579
[TBL] [Abstract][Full Text] [Related]
59. Co-operating ATP sites in the multiple drug resistance transporter Mdr1.
Buxbaum E
Eur J Biochem; 1999 Oct; 265(1):54-63. PubMed ID: 10491157
[TBL] [Abstract][Full Text] [Related]
60. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.
Garrigos M; Mir LM; Orlowski S
Eur J Biochem; 1997 Mar; 244(2):664-73. PubMed ID: 9119038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
